Cutler Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,700	Closed	-$12K	–	7205
2021 Q2	$12K	Buy	2,700 +700	+35%	+$120K	﹤0.01%	3773
2021 Q1	$7K	Sell	2,000 -3,000	-60%	-$464K	﹤0.01%	4183
2020 Q4	$11K	Buy	5,000 +3,000	+150%	+$386K	﹤0.01%	3163
2020 Q3	$2K	Hold	2,000	–	–	﹤0.01%	4201
2020 Q2	$4K	Sell	2,000 -5,900	-75%	-$626K	﹤0.01%	3539
2020 Q1	$43K	Buy	7,900 +3,400	+76%	+$334K	﹤0.01%	1826
2019 Q4	$27K	Buy	4,500 +3,000	+200%	+$321K	﹤0.01%	2045
2019 Q3	$19K	Sell	1,500 -5,000	-77%	-$564K	﹤0.01%	2232
2019 Q2	$13K	Buy	6,500 +5,000	+333%	+$644K	﹤0.01%	2522
2019 Q1	$7K	Sell	1,500 -5,400	-78%	-$671K	﹤0.01%	2759
2018 Q4	$94K	Sell	6,900 -700	-9%	-$82.7K	0.01%	1067
2018 Q3	$19K	Sell	7,600 -5,500	-42%	-$690K	﹤0.01%	2291
2018 Q2	$25K	Sell	13,100 -500	-4%	-$58.4K	﹤0.01%	2051
2018 Q1	$176K	Sell	13,600 -18,300	-57%	-$2.19M	0.02%	890
2017 Q4	$137K	Sell	31,900 -55,500	-64%	-$6.76M	0.01%	1195
2017 Q3	$261K	Sell	87,400 -119,900	-58%	-$16.3M	0.01%	1005
2017 Q2	$748K	Buy	207,300 +111,200	+116%	+$12.9M	0.03%	515
2017 Q1	$783K	Sell	96,100 -81,000	-46%	-$10.4M	0.04%	471
2016 Q4	$1.21M	Buy	177,100 +89,200	+101%	+$10.9M	0.06%	345
2016 Q3	$1.06M	Sell	87,900 -26,800	-23%	-$3.45M	0.07%	304
2016 Q2	$2.35M	Buy	114,700 +46,200	+67%	+$6.56M	0.17%	124
2016 Q1	$905K	Buy	68,500 +18,800	+38%	+$2.76M	0.09%	297
2015 Q4	$436K	Buy	+49,700	New	+$8.68M	0.04%	692

Other funds holding ALXN